Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 218 | $182,336,147 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
18 Jul 2024 16:54 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 16 Jul 2024 | Sale | 930 | 150.0325 | 139,530 | D |
18 Jul 2024 16:45 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 16 Jul 2024 | Sale | 900 | 150.0411 | 135,037 | D |
18 Jul 2024 16:41 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 16 Jul 2024 | Sale | 7,004 | 149.9986 | 1,050,590 | D |
02 Jul 2024 21:36 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 01 Jul 2024 | Sale | 10,000 | 140.1864 | 1,401,864 | D |
02 Jul 2024 21:09 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 01 Jul 2024 | Sale | 272 | 138.11 | 37,566 | D |
04 Jun 2024 16:23 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 31 May 2024 | Sale | 273 | 136.55 | 37,278 | D |
30 May 2024 16:38 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | 29 May 2024 | Sale | 15,000 | 133.4673 | 2,002,010 | D |
30 May 2024 16:38 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | 29 May 2024 | Sale | 25,000 | 133.4622 | 3,336,555 | D |
21 May 2024 17:35 | NBIX | NEUROCRINE BIOSCIENCES INC | SHARP SHALINI | Director | 17 May 2024 | Sale | 1,106 | 141.9018 | 156,943 | D |
21 May 2024 17:27 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | 17 May 2024 | Sale | 2,100 | 141.8383 | 297,860 | D |
21 May 2024 17:06 | NBIX | NEUROCRINE BIOSCIENCES INC | NORWALK LESLIE V | Director | 17 May 2024 | Sale | 1,106 | 141.8173 | 156,850 | D |
16 May 2024 16:55 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 14 May 2024 | Sale | 12,500 | 135.6296 | 1,695,370 | D |
16 May 2024 16:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 15 May 2024 | Sale | 15,000 | 140.2406 | 2,103,609 | D |
16 May 2024 16:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 14 May 2024 | Sale | 15,000 | 135.6551 | 2,034,826 | D |
08 May 2024 16:26 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 06 May 2024 | Sale | 273 | 140.55 | 38,370 | D |
17 Apr 2024 17:19 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 15 Apr 2024 | Sale | 12,587 | 133.3646 | 1,678,660 | D |
17 Apr 2024 17:19 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 15 Apr 2024 | Sale | 7,231 | 133.3646 | 964,359 | D |
03 Apr 2024 16:44 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 01 Apr 2024 | Sale | 272 | 137.3 | 37,346 | D |
25 Mar 2024 18:02 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 21 Mar 2024 | Sale | 5,000 | 145.064 | 725,320 | D |
06 Sep 2023 16:25 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 01 Sep 2023 | Sale | 5,000 | 110.0631 | 550,316 | D |
06 Sep 2023 16:22 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 01 Sep 2023 | Sale | 824 | 110.93 | 91,406 | D |
01 Sep 2023 16:36 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 30 Aug 2023 | Sale | 1,438 | 108.2218 | 155,623 | D |
01 Sep 2023 16:36 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 30 Aug 2023 | Sale | 1,295 | 106.9 | 138,436 | D |
30 Aug 2023 16:38 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 28 Aug 2023 | Sale | 1,431 | 107.52 | 153,861 | D |
23 Aug 2023 20:20 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 21 Aug 2023 | Sale | 3,198 | 107.3758 | 343,388 | D |
23 Aug 2023 20:09 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 21 Aug 2023 | Sale | 2,132 | 107.388 | 228,951 | D |
23 Aug 2023 20:10 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 21 Aug 2023 | Sale | 3,198 | 107.3696 | 343,368 | D |
23 Aug 2023 20:04 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 21 Aug 2023 | Sale | 1,404 | 107.4219 | 150,820 | D |
23 Aug 2023 20:05 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 21 Aug 2023 | Sale | 2,132 | 107.4075 | 228,993 | D |
23 Aug 2023 20:08 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 21 Aug 2023 | Sale | 9,328 | 107.3988 | 1,001,816 | D |
23 Aug 2023 20:01 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 21 Aug 2023 | Sale | 1,600 | 107.4138 | 171,862 | D |
23 Aug 2023 20:03 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 21 Aug 2023 | Sale | 2,132 | 107.4065 | 228,991 | D |
23 Aug 2023 19:58 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 21 Aug 2023 | Sale | 2,132 | 107.3914 | 228,958 | D |
23 Aug 2023 19:59 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 21 Aug 2023 | Sale | 1,600 | 107.3975 | 171,836 | D |
03 May 2023 17:34 | NBIX | NEUROCRINE BIOSCIENCES INC | RASTETTER WILLIAM H | Director | 01 May 2023 | Sale | 4,300 | 101.4268 | 436,135 | D |
03 May 2023 17:28 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 01 May 2023 | Sale | 11,397 | 103.8913 | 1,184,049 | D |
27 Apr 2023 16:37 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 25 Apr 2023 | Sale | 100 | 103.82 | 10,382 | D |
26 Apr 2023 21:22 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 24 Apr 2023 | Sale | 14,400 | 103.4763 | 1,490,059 | D |
21 Apr 2023 18:58 | NBIX | NEUROCRINE BIOSCIENCES INC | RASTETTER WILLIAM H | Director | 21 Apr 2023 | Sale | 6,034 | 105.0359 | 633,787 | D |
21 Apr 2023 18:58 | NBIX | NEUROCRINE BIOSCIENCES INC | RASTETTER WILLIAM H | Director | 19 Apr 2023 | Sale | 903 | 105.004 | 94,819 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 08 Feb 2023 | Sale | 628 | 103.69 | 65,117 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 08 Feb 2023 | Sale | 700 | 103.9514 | 72,766 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 07 Feb 2023 | Sale | 822 | 104.03 | 85,513 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 07 Feb 2023 | Sale | 12,801 | 102.4073 | 1,310,916 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 07 Feb 2023 | Sale | 913 | 102.2457 | 93,350 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 06 Feb 2023 | Sale | 575 | 104.28 | 59,961 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 06 Feb 2023 | Sale | 640 | 105.4659 | 67,498 | D |
08 Feb 2023 19:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 08 Feb 2023 | Sale | 980 | 104.1551 | 102,072 | D |
08 Feb 2023 19:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 07 Feb 2023 | Sale | 12,801 | 102.4075 | 1,310,918 | D |
08 Feb 2023 19:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 07 Feb 2023 | Sale | 1,623 | 102.35 | 166,114 | D |
08 Feb 2023 19:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 06 Feb 2023 | Sale | 1,121 | 105.8004 | 118,602 | D |
08 Feb 2023 19:35 | NBIX | NEUROCRINE BIOSCIENCES INC | LLOYD-SMITH MALCOLM | Chief Integration Officer | 08 Feb 2023 | Sale | 701 | 103.8296 | 72,785 | D |
08 Feb 2023 19:35 | NBIX | NEUROCRINE BIOSCIENCES INC | LLOYD-SMITH MALCOLM | Chief Integration Officer | 07 Feb 2023 | Sale | 12,801 | 102.4108 | 1,310,961 | D |
08 Feb 2023 19:35 | NBIX | NEUROCRINE BIOSCIENCES INC | LLOYD-SMITH MALCOLM | Chief Integration Officer | 07 Feb 2023 | Sale | 1,015 | 102.1609 | 103,693 | D |
08 Feb 2023 19:35 | NBIX | NEUROCRINE BIOSCIENCES INC | LLOYD-SMITH MALCOLM | Chief Integration Officer | 06 Feb 2023 | Sale | 801 | 105.8153 | 84,758 | D |
08 Feb 2023 19:38 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 07 Feb 2023 | Sale | 4,508 | 102.2995 | 461,166 | D |
08 Feb 2023 19:32 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 08 Feb 2023 | Sale | 911 | 104.0779 | 94,815 | D |
08 Feb 2023 19:32 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 07 Feb 2023 | Sale | 12,801 | 102.4191 | 1,311,067 | D |
08 Feb 2023 19:32 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 07 Feb 2023 | Sale | 1,522 | 102.2427 | 155,613 | D |
08 Feb 2023 19:32 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 06 Feb 2023 | Sale | 1,041 | 105.8035 | 110,141 | D |
08 Feb 2023 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 08 Feb 2023 | Sale | 980 | 103.9898 | 101,910 | D |
08 Feb 2023 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 07 Feb 2023 | Sale | 12,801 | 102.4114 | 1,310,968 | D |
08 Feb 2023 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 07 Feb 2023 | Sale | 1,623 | 102.2884 | 166,014 | D |
08 Feb 2023 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 06 Feb 2023 | Sale | 1,600 | 105.6422 | 169,028 | D |
08 Feb 2023 19:28 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 08 Feb 2023 | Sale | 2,274 | 104.3028 | 237,185 | D |
08 Feb 2023 19:28 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 07 Feb 2023 | Sale | 20,482 | 102.4338 | 2,098,049 | D |
08 Feb 2023 19:28 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 07 Feb 2023 | Sale | 3,248 | 102.2985 | 332,266 | D |
08 Feb 2023 19:28 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 06 Feb 2023 | Sale | 3,040 | 105.6772 | 321,259 | D |
08 Feb 2023 19:22 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 08 Feb 2023 | Sale | 700 | 104.1086 | 72,876 | D |
08 Feb 2023 19:22 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 07 Feb 2023 | Sale | 11,497 | 102.421 | 1,177,534 | D |
08 Feb 2023 19:22 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 07 Feb 2023 | Sale | 12,801 | 102.4127 | 1,310,985 | D |
08 Feb 2023 19:22 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 06 Feb 2023 | Sale | 240 | 105.609 | 25,346 | D |
08 Feb 2023 19:16 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 08 Feb 2023 | Sale | 980 | 104.1939 | 102,110 | D |
08 Feb 2023 19:16 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 07 Feb 2023 | Sale | 11,491 | 102.4013 | 1,176,693 | D |
08 Feb 2023 19:16 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 07 Feb 2023 | Sale | 12,807 | 102.4196 | 1,311,688 | D |
08 Feb 2023 19:16 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 07 Feb 2023 | Sale | 2,030 | 102.3278 | 207,725 | D |
08 Feb 2023 19:16 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 06 Feb 2023 | Sale | 1,280 | 105.6667 | 135,253 | D |
08 Feb 2023 19:18 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 08 Feb 2023 | Sale | 980 | 104.1184 | 102,036 | D |
08 Feb 2023 19:18 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 07 Feb 2023 | Sale | 15,360 | 102.4235 | 1,573,225 | D |
08 Feb 2023 19:18 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 07 Feb 2023 | Sale | 2,030 | 102.2872 | 207,643 | D |
08 Feb 2023 19:18 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 06 Feb 2023 | Sale | 1,280 | 105.6256 | 135,201 | D |
02 Feb 2023 17:24 | NBIX | NEUROCRINE BIOSCIENCES INC | LLOYD-SMITH MALCOLM | Chief Integration Officer | 31 Jan 2023 | Sale | 1,666 | 110.0183 | 183,290 | D |
02 Feb 2023 17:26 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 31 Jan 2023 | Sale | 126 | 108.48 | 13,668 | D |
02 Feb 2023 17:28 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 31 Jan 2023 | Sale | 1,457 | 109.9887 | 160,254 | D |
02 Feb 2023 17:19 | NBIX | NEUROCRINE BIOSCIENCES INC | GORMAN KEVIN CHARLES | Chief Executive Officer | 31 Jan 2023 | Sale | 2,707 | 110.0839 | 297,997 | D |
02 Feb 2023 17:21 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 31 Jan 2023 | Sale | 1,250 | 109.9712 | 137,464 | D |
02 Feb 2023 17:15 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 31 Jan 2023 | Sale | 1,541 | 109.9847 | 169,486 | D |
02 Feb 2023 17:04 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 31 Jan 2023 | Sale | 1,104 | 109.9172 | 121,349 | D |
02 Feb 2023 17:07 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 31 Jan 2023 | Sale | 916 | 108.48 | 99,368 | D |
02 Feb 2023 17:00 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 31 Jan 2023 | Sale | 1,207 | 109.9505 | 132,710 | D |
02 Feb 2023 16:53 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 31 Jan 2023 | Sale | 1,283 | 109.9827 | 141,108 | D |
10 Jan 2023 17:13 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 06 Jan 2023 | Sale | 400 | 125 | 50,000 | D |
05 Jan 2023 18:21 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | 03 Jan 2023 | Sale | 15,000 | 118.8501 | 1,782,752 | D |
05 Jan 2023 18:21 | NBIX | NEUROCRINE BIOSCIENCES INC | SHERWIN STEPHEN A | Director | 03 Jan 2023 | Sale | 15,000 | 118.8651 | 1,782,976 | D |
05 Jan 2023 18:18 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | 03 Jan 2023 | Sale | 15,000 | 119.203 | 1,788,045 | D |
01 Dec 2022 18:43 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 30 Nov 2022 | Sale | 20,063 | 125.9017 | 2,525,966 | D |
01 Dec 2022 18:43 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 30 Nov 2022 | Sale | 7,775 | 125.9017 | 978,886 | D |
01 Dec 2022 18:43 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 30 Nov 2022 | Sale | 22,162 | 125.9017 | 2,790,233 | D |
01 Dec 2022 18:35 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 29 Nov 2022 | Sale | 2,331 | 121.9048 | 284,160 | D |
10 Nov 2022 17:50 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 10 Nov 2022 | Sale | 100 | 125.362 | 12,536 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)